SCHEMBL10028544

SCHEMBL10028544

CSCCC(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22688033 0.79
SCHEMBL4572037 0.78
SCHEMBL13594467 0.78
SCHEMBL8044370 0.78
SCHEMBL18504425 0.78
SCHEMBL15107342 0.78
SCHEMBL12518152 0.78
SCHEMBL21261504 0.77 RNPEP (0.42)
SCHEMBL17404624 0.77
SCHEMBL5571273 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023180282-A1 CO-PRECIPITATES OF METHIONYLMETHIONINE WITH ORGANIC COMPOUNDS EVONIK OPERATIONS GMBH (DE) 2023-09-28 WO disclosed
US-11564971-B2 Hyaluronic acid derivative having amino acid and steryl group introduced thereinto CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-01-31 US disclosed
WO-2022144292-A1 PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE EVONIK OPERATIONS GMBH (DE) 2022-07-07 WO disclosed
US-20220160849-A1 CANCER VACCINE FORMULATION MIE UNIVERSITY (JP) 2022-05-26 US disclosed
EP-3919072-A1 CANCER VACCINE PREPARATION Mie University (JP) 2021-12-08 EP disclosed
US-20150231268-A1 HYALURONIC ACID DERIVATIVE HAVING AMINO ACID AND STERYL GROUP INTRODUCED THEREINTO CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2015-08-20 US disclosed
US-20150231268-A1 HYALURONIC ACID DERIVATIVE HAVING AMINO ACID AND STERYL GROUP INTRODUCED THEREINTO CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2015-08-20 US disclosed
EP-2431356-A1 Peptidomimetic methionine derivatives as well as their use in the protection of skin cells Exsymol S.A.M. (MC) 2012-03-21 EP disclosed
US-7365090-B2 Substituted phenylindoles for the treatment of HIV IDENIX PHARMACEUTICALS, INC. (US) 2008-04-29 US disclosed